Arecor Therapeutics (LON:AREC) Shares Down 2.6% – Should You Sell?

Arecor Therapeutics plc (LON:AREC) shares were down 2.6% during trading on Friday . The stock traded as low as GBX 57 ($0.71) and last traded at GBX 57 ($0.71). Approximately 687 shares were traded during mid-day trading, a decline of 90% from the average daily volume of 6,614 shares. The stock had previously closed at GBX 58.50 ($0.72).

Arecor Therapeutics Stock Performance

The company has a debt-to-equity ratio of 5.51, a quick ratio of 6.24 and a current ratio of 1.37. The firm has a market capitalization of £21.52 million, a P/E ratio of -203.57 and a beta of -0.18. The company has a 50-day simple moving average of GBX 68.12 and a two-hundred day simple moving average of GBX 75.57.

About Arecor Therapeutics

Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.